The International Diabetes Federation European Region (IDF Europe) announced the conclusion of two Corporate Partnerships with pharmaceutical company Janssen and medical devices company Ypsomed.
The new partnerships mean IDF Europe has another two key players in Europe in the fight against diabetes and in efforts to improve diabetes care, prevention and education in the region. João Nabais, IDF Europe President, commented: “We are delighted to welcome Janssen and Ypsomed as new Corporate Partners of our Federation. These partnerships are essential to support our mission to improve the lives of the millions of people living with diabetes in Europe and prevent others from developing the condition”.
Along with the new partnerships, João Nabais acknowledged the continuous and valuable support from all IDF Europe partners from the pharmaceutical and medical devices industries, as well as all the national and local diabetes associations for their remarkable work in the fight against diabetes in Europe.
Diabetes rates in Europe are on the increase. The latest estimates show that 55 million people live with diabetes in the region and that at least an additional 21.2 million people are yet to be diagnosed.
For more information on IDF Europe partnerships, click here.